Announced
Completed
Financials
Tags
Private Equity
United States
Acquisition
Single Bidder
Private
Biotechnology
Friendly
Minority
Domestic
biotechnology
Venture Capital
Completed
Synopsis
Tiger Global led a $133m Series E funding round in Virta Health, a company developing type 2 diabetes reversal. “The norm in diabetes care has been more medications, more weight gain, and more suffering. Diabetes reversal changes this. We have shown a path for people to live medication and diabetes-free, and this investment is about reaching even more people and taking diabetes reversal mainstream,” Sami Inkinen, Virta Health Co-Founder and CEO.
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.